Additionally, previous studies have indicated that inflammatory mediators such as C-reactive protein (CRP) and interleukin-6 (IL-6) undergo changes during the acute phase of stroke, serving as potential biomarkers for stroke prognosis or imminent complications5. This evidence concerns the gene CRP and stroke disorder.